Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s New Chief Medical Officer Is Tackling Califf’s Top Priorities
Oct 11 2022
•
By
Sarah Karlin-Smith
FDA CMO Hilary Marston discussed her three buckets of responsibility with the Pink Sheet. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from US FDA
More from Agency Leadership